LETROZOLE CIPLA letrozole 2.5mg film-coated tablet blister pack

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

letrozole, Quantity: 2.5 mg

Saatavilla:

Cipla Australia Pty Ltd

INN (Kansainvälinen yleisnimi):

Letrozole

Lääkemuoto:

Tablet, film coated

Koostumus:

Excipient Ingredients: lactose monohydrate; sodium starch glycollate; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 400

Antoreitti:

Oral

Kpl paketissa:

30, 10

Prescription tyyppi:

(S4) Prescription Only Medicine

Käyttöaiheet:

For the treatment of postmenopausal women with hormone receptor positive breast cancer (see Clinical Trials). The safety and efficacy of neoadjuvant use of letrozole has not been established. Letrozole is not indicated in hormone receptor negative disease.

Tuoteyhteenveto:

Visual Identification: Yellow circular, biconvex, film coated tablet debossed with LT on one side and 2.5 on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Valtuutuksen tilan:

Licence status A

Valtuutus päivämäärä:

2016-06-01